Gyre Therapeutics GYRE
NASDAQ GYRE
$5.85 -0.01 (-0.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gyre Therapeutics (GYRE) Sale and Maturity of Investments (2012 - 2026)

Updated

Analysis

Gyre Therapeutics (GYRE) Sale and Maturity of Investments (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Gyre Therapeutics 620.30 Mn 423.01 Mn 26.90 Mn 2.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.92 Mn
Mar 31, 2026 10.07 Mn
Dec 31, 2025 4.24 Mn
Sep 30, 2025 -12.00 Mn
Jun 30, 2025 12.00 Mn
Mar 31, 2025 11.19 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.87 Mn
Sep 30, 2021 7.53 Mn
Jun 30, 2021 11.05 Mn
Mar 31, 2021 27.58 Mn
Dec 31, 2020 33.48 Mn
Sep 30, 2020 23.59 Mn
Jun 30, 2020 17.04 Mn
Mar 31, 2020 33.46 Mn
Dec 31, 2019 23.47 Mn
Sep 30, 2019 44.96 Mn
Jun 30, 2019 40.73 Mn
Mar 31, 2019 48.27 Mn
Dec 31, 2018 67.63 Mn
API Access

Gyre Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=GYRE&period=max&api_key=YOUR_API_KEY